Exane Derivatives’s Viacom Inc. Class B VIAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3
Closed -$84 751
2019
Q1
$84 Hold
3
﹤0.01% 587
2018
Q4
$77 Sell
3
-4,315
-100% -$133K ﹤0.01% 648
2018
Q3
$145K Sell
4,318
-1,533
-26% -$46K 0.03% 279
2018
Q2
$177K Sell
5,851
-3,062
-34% -$90.1K 0.03% 273
2018
Q1
$272K Sell
8,913
-6,941
-44% -$224K 0.05% 220
2017
Q4
$488K Buy
15,854
+6,147
+63% +$167K 0.08% 166
2017
Q3
$270K Buy
9,707
+7,238
+293% +$223K 0.05% 182
2017
Q2
$82.9K Buy
2,469
+2,466
+82,200% +$93.9K 0.02% 288
2017
Q1
$140 Buy
+3
New +$127 ﹤0.01% 476

Other funds holding VIAB

Exane Derivatives's VIAB Position: Q2 2019 in Review

Exane Derivatives sold out of Viacom Inc. Class B (VIAB) in Q2 2019, closing a stake of 3 shares — an estimated $84 sold.

Exane Derivatives first reported a position in VIAB in Q1 2017 and held it in 9 quarters. The position peaked at $488K in Q4 2017. 622 funds tracked by Wall St. Rank hold VIAB as of Q2 2019.

  • Exane Derivatives reported no remaining Viacom Inc. Class B position as of Q2 2019 after selling out during the quarter.
  • Exane Derivatives sold 3 Viacom Inc. Class B shares in Q2 2019, an estimated $84.
  • Exane Derivatives first reported a position in Viacom Inc. Class B in Q1 2017 and held it in 9 quarters.
  • Exane Derivatives's Viacom Inc. Class B position peaked at $488K in Q4 2017.
  • 622 funds tracked by Wall St. Rank held Viacom Inc. Class B as of Q2 2019.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.